The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
00
The Journey from a Solid to a Biotech Production Site
R-Pharm Germany has set up a biotechnical plant at its Illertissen site. Driven by the pandemic situation, a production area for vaccines and one for monoclonal antibodies (MAB) were established. In a very ambitious timeline, all the necessary infrastructure and supporting functions were also built.